笔者最近在《医药经济报》上写了一篇题为《民企,在春天中起舞》的时评,为近年来崛起的医药民营企业鼓掌。确实,十六大后,全国各地的民营经济迎来了前所未有的发展机遇。原来门槛较高而成长性强的医药行业成为业外民营经济追逐的热点。 The author recently wrote a commentary entitled “Private Enterprises, Dancing in the Spring” in the “Medical and Economic News”, applauding the rise of pharmaceutical private enterprises in recent years. Indeed, after the 16th CPC National Congress, the private economy across the country ushered in unprecedented opportunities for development. The original high threshold and strong growth of the pharmaceutical industry has become a private economy outside the chase.